Cellevolve

Cellevolve develops and commercialises cell therapies aimed at neglected diseases. The company argues that advances in this field are now produced in many settings around the world, and it works with those innovators to take clinical-stage therapies through later development towards the market.

What Cellevolve offers

• Late-stage development — moves clinical-stage cell therapies through the later phases of clinical work.
• Commercialisation — brings developed therapies towards the market.
• Cell therapy manufacturing — produces therapies as part of its own development model.
• Cellution platform — a specialised platform that combines technologies, partners and Cellevolve's own teams into a customised model for each therapy.

Who it works with

Its partners are global innovators whose therapeutic advances originate in many different settings. Its focus is on diseases that receive little attention from the wider industry.